{
  "meta": {
    "title": "03_Anti_Arrhythmic_Drugs",
    "url": "https://brainandscalpel.vercel.app/03-anti-arrhythmic-drugs-a53223b2.html",
    "scrapedAt": "2025-11-30T06:59:35.089Z"
  },
  "questions": [
    {
      "id": 60929,
      "choices": [
        {
          "id": 294297,
          "text": "By decreasing cardiac contractility"
        },
        {
          "id": 294298,
          "text": "Increase in Refractoriness of AV nodal tissue"
        },
        {
          "id": 294299,
          "text": "Na+ K+ ATPase inhibition"
        },
        {
          "id": 294300,
          "text": "By causing Bradycardia"
        }
      ],
      "text": "Mechanism of action of digitalis in atrial fibrillation is",
      "unique_key": "Q7887327",
      "question_audio": null,
      "question_video": null,
      "map_id": 34383448,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Increase in refractoriness of AV nodal tissue. Digitalis (digoxin) is used in atrial fibrillation primarily to slow ventricular rate by increasing the refractoriness of the atrioventricular (AV) node. It achieves this effect by enhancing vagal (parasympathetic) tone, which reduces conduction velocity through the AV node and prolongs its effective refractory period. This action prevents rapid atrial impulses from being transmitted to the ventricles, thereby controlling the heart rate in atrial fibrillation. Unlike beta-blockers or calcium channel blockers, digoxin does not directly affect atrial fibrillation itself but helps in rate control by modulating AV nodal conduction. Incorrect Options: (A) By decreasing cardiac contractility: This is incorrect because digoxin increases cardiac contractility (positive inotropic effect) by inhibiting Na+/K+-ATPase, leading to increased intracellular calcium. While digoxin slows the heart rate in atrial fibrillation, it does not reduce contractility; in fact, it is used in heart failure for its contractility-enhancing effects. (C) Na+/K+ ATPase inhibition: While digoxin does inhibit the Na+/K+-ATPase pump, leading to increased intracellular calcium and positive inotropy, this mechanism is not directly responsible for its action in atrial fibrillation. The rate-controlling effect in atrial fibrillation is primarily due to increased vagal activity and prolonged AV nodal refractoriness, rather than Na+/K+-ATPase inhibition itself. (D) By causing bradycardia: Digoxin can cause bradycardia, especially in high doses or toxicity, due to its vagal effects. However, bradycardia is not the primary mechanism by which it controls atrial fibrillation. Instead, it works by increasing AV nodal refractoriness, which reduces excessive ventricular response to atrial fibrillation.",
      "correct_choice_id": 294298,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7173771698477958/7173771698477958.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7173771698477958/7173771698477958.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60930,
      "choices": [
        {
          "id": 294301,
          "text": "Restoration of normal sinus rhythm"
        },
        {
          "id": 294302,
          "text": "Conversion of atrial fibrillation to atrial flutter"
        },
        {
          "id": 294303,
          "text": "Decrease in atrial fibrillation frequency but increase in ventricular rate"
        },
        {
          "id": 294304,
          "text": "Increase in atrial fibrillation frequency, but decrease in ventricular rate"
        }
      ],
      "text": "A patient of atrial fibrillation is on digoxin therapy. Which of the following responses do you expect?",
      "unique_key": "Q4099198",
      "question_audio": null,
      "question_video": null,
      "map_id": 34813307,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Increase in atrial fibrillation frequency, but decrease in ventricular rate. Digoxin is a cardiac glycoside that acts primarily by inhibiting the Na+/K+-ATPase pump, leading to increased intracellular calcium and enhanced myocardial contractility (positive inotropic effect). However, in atrial fibrillation (AF), its main therapeutic effect comes from enhancing vagal (parasympathetic) tone, which slows conduction through the atrioventricular (AV) node, reducing the ventricular rate. Since digoxin does not directly affect atrial tissue, it does not stop atrial fibrillation and may even allow atrial fibrillation to persist or increase in frequency. However, it still provides symptomatic benefit by controlling the ventricular rate, which is critical in managing AF. Incorrect Options: (A) Restoration of normal sinus rhythm: This is incorrect because digoxin does not convert atrial fibrillation to normal sinus rhythm. Unlike class I or III antiarrhythmic drugs (e.g., amiodarone, flecainide), digoxin has no direct antiarrhythmic effect on the atria. It only slows AV nodal conduction, helping to control the ventricular response but not stopping AF itself. (B) Conversion of atrial fibrillation to atrial flutter: This is incorrect because digoxin does not cause conversion of AF to atrial flutter. Atrial flutter and atrial fibrillation are different types of arrhythmias, and while flutter can sometimes degenerate into fibrillation, digoxin does not promote this conversion. Instead, it simply slows conduction at the AV node, reducing ventricular response. (C) Decrease in atrial fibrillation frequency but increase in ventricular rate: This is incorrect because while digoxin controls the ventricular rate by reducing AV nodal conduction, it does not decrease the frequency of atrial fibrillation. If anything, increased vagal tone may facilitate AF in some cases. Also, an increase in ventricular rate would be opposite to digoxin's expected effect, as it is primarily used to slow the ventricular response in atrial fibrillation.",
      "correct_choice_id": 294304,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60931,
      "choices": [
        {
          "id": 294305,
          "text": "Verapamil"
        },
        {
          "id": 294306,
          "text": "Adenosine"
        },
        {
          "id": 294307,
          "text": "Digoxin"
        },
        {
          "id": 294308,
          "text": "Propanolol"
        }
      ],
      "text": "Which of the following drugs hyperpolarizes AV nodal tissue, is used in PSVT and has short lasting adverse effects?",
      "unique_key": "Q5781715",
      "question_audio": null,
      "question_video": null,
      "map_id": 34206121,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Adenosine. Adenosine is a rapid-acting antiarrhythmic drug used for the acute termination of paroxysmal supraventricular tachycardia (PSVT). It works by hyperpolarizing AV nodal tissue through activation of A1 adenosine receptors, which enhances potassium efflux and inhibits calcium influx, leading to transient AV node blockade. This effect interrupts the reentrant circuit in AV nodal-dependent arrhythmias (such as PSVT), restoring normal sinus rhythm. Adenosine is characterized by extremely short-lasting adverse effects due to its very short half-life (~10 seconds). Common side effects include flushing, chest discomfort, hypotension, dyspnea, and transient bradycardia, but they resolve quickly without long-term complications. Explanation of Incorrect Options: (A) Verapamil – Incorrect Verapamil is a Class IV antiarrhythmic (calcium channel blocker) that also blocks AV node conduction and can be used in PSVT. However, unlike adenosine, it does not cause hyperpolarization of AV nodal tissue; instead, it reduces calcium influx into cardiac cells, slowing conduction. Additionally, verapamil has a longer duration of action compared to adenosine and may cause more sustained hypotension and bradycardia. (C) Digoxin – Incorrect Digoxin enhances vagal tone, leading to AV nodal inhibition and is used in rate control of atrial fibrillation. However, it is not the drug of choice for PSVT and does not work by directly hyperpolarizing AV nodal tissue. Additionally, digoxin toxicity can lead to arrhythmias rather than terminate PSVT. (D) Propranolol – Incorrect Propranolol is a non-selective beta-blocker (Class II antiarrhythmic) that reduces AV nodal conduction by inhibiting sympathetic stimulation. While it can be used for rate control in atrial arrhythmias, it is not the first-line treatment for PSVT and does not cause rapid hyperpolarization of AV nodal tissue like adenosine. Additionally, its effects last much longer than adenosine.",
      "correct_choice_id": 294306,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/77090531698478694/77090531698478694.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/77090531698478694/77090531698478694.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60932,
      "choices": [
        {
          "id": 294309,
          "text": "Digitalis induced ventricular extrasystoles"
        },
        {
          "id": 294310,
          "text": "Paroxysmal supraventricular tachycardia"
        },
        {
          "id": 294311,
          "text": "Atrial fibrillation"
        },
        {
          "id": 294312,
          "text": "All of the above"
        }
      ],
      "text": "Lignocaine is useful for the treatment of",
      "unique_key": "Q8273631",
      "question_audio": null,
      "question_video": null,
      "map_id": 34506604,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Digitalis-induced ventricular extrasystoles. Lignocaine (lidocaine) is a Class IB antiarrhythmic drug that acts by blocking sodium channels, specifically affecting depolarized or ischemic ventricular myocardium. It is particularly useful in treating ventricular arrhythmias, especially those induced by digitalis toxicity. Digitalis (digoxin) toxicity can lead to increased automaticity and delayed afterdepolarizations, causing ventricular extrasystoles, ventricular tachycardia, or fibrillation. Lignocaine shortens the action potential duration and suppresses ectopic ventricular activity, making it an effective drug in this setting. Explanation of Incorrect Options: (B) Paroxysmal supraventricular tachycardia (PSVT) – Incorrect Lignocaine is not effective for PSVT, as this arrhythmia originates from the atrioventricular (AV) node or atria, and lignocaine primarily affects ventricular arrhythmias. Instead, adenosine, verapamil, or beta-blockers are preferred for PSVT. (C) Atrial fibrillation – Incorrect Lignocaine does not work well for atrial arrhythmias, including atrial fibrillation, because it does not significantly affect atrial tissue. Beta-blockers, calcium channel blockers (e.g., diltiazem, verapamil), amiodarone, or anticoagulation therapy are typically used to manage atrial fibrillation. (D) All of the above – Incorrect Since lignocaine is not effective for PSVT or atrial fibrillation, but is useful in digitalis-induced ventricular extrasystoles, the option \"All of the above\" is incorrect.",
      "correct_choice_id": 294309,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2177611698478730/2177611698478730.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2177611698478730/2177611698478730.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60933,
      "choices": [
        {
          "id": 294313,
          "text": "It blocks myocardial Na+ channels primarily in the open state"
        },
        {
          "id": 294314,
          "text": "It delays recovery of myocardial Na+ channels"
        },
        {
          "id": 294315,
          "text": "It produces frequency dependent blockade of myocardial Na+ channels"
        },
        {
          "id": 294316,
          "text": "It has no effect on myocardial K+ channels"
        }
      ],
      "text": "All of the following statements are true about quinidine except",
      "unique_key": "Q6181159",
      "question_audio": null,
      "question_video": null,
      "map_id": 34618785,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) It has no effect on myocardial K+ channels. Quinidine is a Class IA antiarrhythmic drug that blocks both Na+ and K+ channels in cardiac tissue. While it primarily blocks sodium (Na+) channels, it also inhibits potassium (K+) channels, leading to prolongation of the action potential duration and QT interval. This potassium channel blockade can increase the risk of torsades de pointes (a type of polymorphic ventricular tachycardia). Since quinidine does affect myocardial K+ channels, option D is incorrect. Explanation of Incorrect Options: (A) It blocks myocardial Na+ channels primarily in the open state – Correct Quinidine preferentially binds to Na+ channels in their open (activated) state, which reduces sodium influx during phase 0 of the action potential, slowing conduction velocity in cardiac tissue. This characteristic is typical of Class IA antiarrhythmic drugs. (B) It delays recovery of myocardial Na+ channels – Correct Quinidine prolongs the refractory period by delaying the recovery of sodium channels from inactivation, making the cardiac cells less excitable and reducing the likelihood of reentrant arrhythmias. This contributes to its antiarrhythmic action. (C) It produces frequency-dependent blockade of myocardial Na+ channels – Correct Quinidine exhibits frequency-dependent (use-dependent) blockade, meaning that it is more effective at higher heart rates because it preferentially binds to sodium channels that are frequently activated. This property is beneficial in tachyarrhythmias since it selectively suppresses rapidly depolarizing tissues while sparing normal cardiac conduction at lower heart rates.",
      "correct_choice_id": 294316,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61047171698478751/61047171698478751.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61047171698478751/61047171698478751.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60934,
      "choices": [
        {
          "id": 294317,
          "text": "Quinidine"
        },
        {
          "id": 294318,
          "text": "Propanolol"
        },
        {
          "id": 294319,
          "text": "Lignocaine"
        },
        {
          "id": 294320,
          "text": "Adenosine"
        }
      ],
      "text": "Which of the following antiarrhythmic drugs can decrease the slope of Phase 0 and prolong the action potential duration?",
      "unique_key": "Q7354798",
      "question_audio": null,
      "question_video": null,
      "map_id": 34389075,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Quinidine. Quinidine is a Class IA antiarrhythmic drug that works by blocking sodium (Na+) and potassium (K+) channels in cardiac tissue. It decreases the slope of Phase 0 of the cardiac action potential by inhibiting Na+ influx, which slows conduction velocity. Additionally, quinidine blocks K+ channels, leading to prolongation of the action potential duration (APD) and the QT interval. This combination of effects makes it useful for treating atrial and ventricular arrhythmias, but it also increases the risk of torsades de pointes due to QT prolongation. Incorrect Options: (B) Propranolol – Incorrect Propranolol is a Class II antiarrhythmic drug (beta-blocker) that primarily inhibits sympathetic stimulation of the heart. It does not block sodium or potassium channels and therefore does not decrease the slope of Phase 0 or prolong the action potential duration. Instead, it reduces heart rate and AV nodal conduction by inhibiting β1 receptors. (C) Lignocaine – Incorrect Lignocaine (lidocaine) is a Class IB antiarrhythmic drug that selectively blocks Na+ channels in ischemic or depolarized ventricular tissue. Unlike quinidine, it shortens the action potential duration rather than prolonging it. Additionally, it has a weaker effect on Phase 0, meaning it does not significantly slow conduction in normal cardiac tissue. (D) Adenosine – Incorrect Adenosine is not a sodium or potassium channel blocker. Instead, it activates A1 adenosine receptors, which enhances K+ efflux (hyperpolarization) and inhibits Ca2+ influx in the AV node. This leads to transient AV nodal block, making it effective for terminating paroxysmal supraventricular tachycardia (PSVT). However, it does not affect Phase 0 or action potential duration in ventricular myocytes, making it incorrect for this question.",
      "correct_choice_id": 294317,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/20692321698478774/20692321698478774.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/20692321698478774/20692321698478774.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60935,
      "choices": [
        {
          "id": 294321,
          "text": "Amiodarone"
        },
        {
          "id": 294322,
          "text": "Quinidine"
        },
        {
          "id": 294323,
          "text": "Esmolol"
        },
        {
          "id": 294324,
          "text": "Verapamil"
        }
      ],
      "text": "All of the following drugs can be used for the chronic oral treatment of arrhythmia except",
      "unique_key": "Q2576718",
      "question_audio": null,
      "question_video": null,
      "map_id": 34279789,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Esmolol. Esmolol is a Class II antiarrhythmic drug (beta-blocker) that is ultra-short-acting due to its rapid metabolism by esterases in red blood cells. It is administered intravenously (IV) only and has a very short half-life (~9 minutes). Because of its rapid onset and short duration of action, esmolol is used for acute arrhythmias, such as supraventricular tachycardia (SVT), atrial fibrillation, and atrial flutter, especially in perioperative and emergency settings. It is not suitable for chronic oral therapy. Explanation of Incorrect Options: (A) Amiodarone – Correct Amiodarone is a Class III antiarrhythmic drug with potent antiarrhythmic effects and a very long half-life (several weeks to months). It can be used orally for chronic suppression of atrial and ventricular arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. Despite its efficacy, it has multiple long-term side effects, such as pulmonary fibrosis, thyroid dysfunction, and liver toxicity. (B) Quinidine – Correct Quinidine is a Class IA antiarrhythmic drug that is effective orally for chronic treatment of atrial and ventricular arrhythmias. It works by blocking Na? and K? channels, reducing conduction velocity and prolonging action potential duration. However, its long-term use is limited due to proarrhythmic effects (torsades de pointes) and gastrointestinal side effects. (D) Verapamil – Correct Verapamil is a Class IV antiarrhythmic drug (calcium channel blocker) that is effective orally for the chronic management of supraventricular arrhythmias, such as atrial fibrillation and paroxysmal supraventricular tachycardia (PSVT). It works by blocking L-type calcium channels, slowing AV nodal conduction and decreasing heart rate. However, it is not effective for ventricular arrhythmias.",
      "correct_choice_id": 294323,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/9988331698478794/9988331698478794.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/9988331698478794/9988331698478794.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60936,
      "choices": [
        {
          "id": 294325,
          "text": "Calcium chelation"
        },
        {
          "id": 294326,
          "text": "Sodium lactate"
        },
        {
          "id": 294327,
          "text": "Nitroprusside"
        },
        {
          "id": 294328,
          "text": "KCI"
        }
      ],
      "text": "Urgent treatment of procainamide toxicity is",
      "unique_key": "Q1894988",
      "question_audio": null,
      "question_video": null,
      "map_id": 34862052,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Sodium lactate. Procainamide is a Class IA antiarrhythmic drug that blocks sodium (Na+) channels and prolongs the action potential duration. Toxicity from procainamide can lead to QRS widening, hypotension, and torsades de pointes due to excessive Na+ channel blockade and metabolic acidosis. Sodium lactate is the treatment of choice because: It counteracts Na+ channel blockade by increasing extracellular Na+ concentration, thereby restoring normal depolarization and reducing QRS prolongation. It corrects metabolic acidosis, which is commonly associated with procainamide toxicity. Acidosis exacerbates Na+ channel blockade, so its correction helps improve cardiac function. It stabilizes blood pressure by improving cardiac output and vascular resistance. Incorrect Options: (A) Calcium chelation – Incorrect Calcium chelation is not a treatment for procainamide toxicity. Calcium plays a role in myocardial contraction, but procainamide toxicity primarily affects Na+ channels and potassium repolarization, making calcium chelation ineffective. (C) Nitroprusside – Incorrect Nitroprusside is a vasodilator used in conditions like hypertensive emergencies and heart failure, but it does not reverse Na+ channel blockade or treat metabolic acidosis, making it unsuitable for procainamide toxicity. (D) KCl (Potassium chloride) – Incorrect While procainamide can prolong the QT interval (which is influenced by potassium levels), potassium administration is not the primary treatment. Excessive potassium can even worsen arrhythmias, particularly in cases of torsades de pointes, where magnesium sulfate is preferred over potassium correction.",
      "correct_choice_id": 294326,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/71672521698478813/71672521698478813.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/71672521698478813/71672521698478813.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60937,
      "choices": [
        {
          "id": 294329,
          "text": "Esmolol"
        },
        {
          "id": 294330,
          "text": "Quinidine"
        },
        {
          "id": 294331,
          "text": "Disopyramide"
        },
        {
          "id": 294332,
          "text": "Lignocaine"
        }
      ],
      "text": "Treatment of choice for digitalis induced ventricular arrhythmias is",
      "unique_key": "Q4905326",
      "question_audio": null,
      "question_video": null,
      "map_id": 34970419,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) The correct treatment of choice for digitalis-induced ventricular arrhythmias is Lignocaine (D). Lignocaine, also known as lidocaine, is a Class 1b antiarrhythmic agent that works by blocking sodium channels and stabilizing the cardiac cell membrane. It is particularly effective in treating ventricular arrhythmias, including those induced by digitalis toxicity, because it reduces excitability and slows conduction in the heart's ventricular tissue. Lignocaine is often preferred in emergencies as it has a rapid onset of action and can be administered intravenously. Esmolol (A), a beta-blocker, is not the preferred treatment for digitalis-induced ventricular arrhythmias. While beta-blockers can be useful in controlling heart rate in certain arrhythmias, they are generally not effective in managing the arrhythmias caused by digitalis toxicity. In fact, beta-blockers can sometimes worsen the arrhythmias, especially if there is already a slowed atrioventricular (AV) conduction or bradycardia, which is common in digitalis toxicity. Quinidine (B), a Class 1a antiarrhythmic, is not suitable for digitalis-induced arrhythmias. Quinidine can have proarrhythmic effects, especially in the presence of electrolyte imbalances or digitalis toxicity. It can also increase the risk of torsades de pointes and other dangerous arrhythmias, which makes it a less favorable option for this condition. Disopyramide (C), a Class 1a antiarrhythmic, also carries risks when used in digitalis toxicity. Disopyramide has anticholinergic properties, which can worsen conduction abnormalities, including AV block. Additionally, it can depress myocardial contractility, which may be detrimental in the context of digitalis toxicity, where the heart may already be at risk of diminished contractile function. Therefore, it is not recommended in this setting.",
      "correct_choice_id": 294332,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62120241698479024/62120241698479024.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62120241698479024/62120241698479024.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60938,
      "choices": [
        {
          "id": 294333,
          "text": "Verapamil"
        },
        {
          "id": 294334,
          "text": "Mexiletine"
        },
        {
          "id": 294335,
          "text": "Esmolol"
        },
        {
          "id": 294336,
          "text": "Quinidine"
        }
      ],
      "text": "Which of the following is not used in atrial arrhythmias",
      "unique_key": "Q5773284",
      "question_audio": null,
      "question_video": null,
      "map_id": 34959445,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Mexiletine. Mexiletine is a Class IB antiarrhythmic drug that primarily acts on ventricular arrhythmias by blocking sodium channels in depolarized myocardial cells. Class IB agents like mexiletine and lidocaine have minimal effects on atrial tissue because the atrial action potential is shorter and lacks the prolonged depolarization phase seen in ventricular cells. As a result, mexiletine is ineffective in treating atrial arrhythmias, making it the correct answer. Explanation for incorrect options: Option A: Verapamil – Verapamil is a Class IV antiarrhythmic drug (non-dihydropyridine calcium channel blocker) that slows conduction through the AV node, making it effective in controlling atrial arrhythmias such as atrial fibrillation, atrial flutter, and supraventricular tachycardia (SVT). It is particularly useful in rate control for atrial fibrillation by reducing AV nodal conduction. Option C: Esmolol – Esmolol is a Class II antiarrhythmic drug (beta-blocker) that is short-acting and primarily used in acute atrial arrhythmias. It works by reducing sympathetic activity, thereby slowing AV nodal conduction and controlling the ventricular response in conditions like atrial fibrillation and atrial flutter. Its rapid onset and short half-life make it ideal for emergency situations. Option D: Quinidine – Quinidine is a Class IA antiarrhythmic drug that blocks sodium and potassium channels, prolonging the action potential and refractory period. It is effective in treating both atrial and ventricular arrhythmias, including atrial fibrillation and atrial flutter.",
      "correct_choice_id": 294334,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52724831698479151/52724831698479151.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52724831698479151/52724831698479151.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60939,
      "choices": [
        {
          "id": 294337,
          "text": "Quinidine"
        },
        {
          "id": 294338,
          "text": "Amiodarone"
        },
        {
          "id": 294339,
          "text": "Lignocaine"
        },
        {
          "id": 294340,
          "text": "Verapamil"
        }
      ],
      "text": "DOC for ventricular arrhythmias due to digitalis toxicity is",
      "unique_key": "Q6339249",
      "question_audio": null,
      "question_video": null,
      "map_id": 34566348,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Lignocaine (Lidocaine). Lidocaine is a Class IB antiarrhythmic drug that selectively blocks sodium channels in ischemic or depolarized ventricular myocardium. It is particularly effective in treating ventricular arrhythmias caused by digitalis toxicity because it suppresses abnormal automaticity and ectopic pacemaker activity without significantly affecting normal conduction tissue. Additionally, lidocaine has minimal effects on atrial tissue, making it less likely to worsen atrial arrhythmias or cause AV block, which can be exacerbated by digitalis toxicity. Explanation for incorrect options: Option A: Quinidine – Quinidine is a Class IA antiarrhythmic drug that prolongs the action potential duration and refractory period by blocking sodium and potassium channels. However, it is contraindicated in digitalis toxicity because it can increase digoxin levels by displacing it from tissue-binding sites and inhibiting its renal clearance, worsening toxicity. Option B: Amiodarone – Amiodarone is a Class III antiarrhythmic drug with broad-spectrum activity against both atrial and ventricular arrhythmias. However, it is not the first-line drug for digitalis-induced ventricular arrhythmias, as it may further prolong QT interval and worsen bradyarrhythmias in digitalis toxicity. Option D: Verapamil – Verapamil is a Class IV antiarrhythmic drug (calcium channel blocker) that primarily acts on the AV node. It is not effective for ventricular arrhythmias and is actually contraindicated in digitalis toxicity because it can worsen AV block and cause severe hypotension.",
      "correct_choice_id": 294339,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/66440811698479169/66440811698479169.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/66440811698479169/66440811698479169.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60940,
      "choices": [
        {
          "id": 294341,
          "text": "Adenosine"
        },
        {
          "id": 294342,
          "text": "Nifedipine"
        },
        {
          "id": 294343,
          "text": "Digoxin"
        },
        {
          "id": 294344,
          "text": "Verapamil"
        }
      ],
      "text": "An asthmatic present to the emergency department with PSVT, what will be the drug used for its management",
      "unique_key": "Q6158261",
      "question_audio": null,
      "question_video": null,
      "map_id": 34960773,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Verapamil. Verapamil is a Class IV antiarrhythmic drug (non-dihydropyridine calcium channel blocker) that acts by blocking calcium channels in the AV node, thereby slowing conduction and terminating paroxysmal supraventricular tachycardia (PSVT). It is particularly useful in PSVT management when adenosine is contraindicated, such as in asthmatic patients. Adenosine can trigger bronchospasm, making verapamil the preferred alternative in asthma patients. Explanation for incorrect options: Option A: Adenosine – Although adenosine is the first-line drug for PSVT due to its rapid onset and short half-life, it is contraindicated in asthmatic patients because it can cause severe bronchospasm by activating A1 and A2 receptors in the lungs. This can lead to respiratory distress, making it unsuitable for this patient. Option B: Nifedipine – Nifedipine is a dihydropyridine calcium channel blocker that primarily acts on vascular smooth muscle, causing vasodilation. It does not significantly affect AV nodal conduction, making it ineffective for PSVT termination. Option C: Digoxin – Digoxin has vagomimetic effects, which can slow AV nodal conduction and be useful in some supraventricular arrhythmias. However, it has a slow onset of action and is not suitable for acute PSVT termination. Moreover, its use requires caution due to the risk of digoxin toxicity, especially in patients with renal impairment or electrolyte imbalances.",
      "correct_choice_id": 294344,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/77741621698479192/77741621698479192.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/77741621698479192/77741621698479192.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60941,
      "choices": [
        {
          "id": 294345,
          "text": "Sotalol"
        },
        {
          "id": 294346,
          "text": "Amiodarone"
        },
        {
          "id": 294347,
          "text": "Diltiazem"
        },
        {
          "id": 294348,
          "text": "Quinidine"
        }
      ],
      "text": "Arrhythmias Refractory to the treatment of Lignocaine can be treated by",
      "unique_key": "Q1966316",
      "question_audio": null,
      "question_video": null,
      "map_id": 34079438,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Amiodarone. Amiodarone is a Class III antiarrhythmic drug that works by blocking potassium channels, prolonging the action potential duration and refractory period. It also has sodium, calcium, and beta-blocking properties, making it highly effective in treating ventricular arrhythmias refractory to lidocaine (lignocaine). Lidocaine, a Class IB antiarrhythmic, is used for ventricular arrhythmias, especially in ischemic tissue, but if it fails, amiodarone is the preferred alternative due to its broad-spectrum antiarrhythmic effects. Explanation for incorrect options: Option A: Sotalol – Sotalol is a Class III antiarrhythmic drug with additional beta-blocking properties. While it is used for ventricular arrhythmias, it is not the first-line alternative to lidocaine due to its potential for QT prolongation and torsades de pointes. Amiodarone is preferred in refractory cases because it has a lower proarrhythmic risk compared to sotalol. Option C: Diltiazem – Diltiazem is a Class IV antiarrhythmic drug (calcium channel blocker) that primarily affects the AV node and is used for supraventricular arrhythmias (e.g., atrial fibrillation, PSVT). It does not effectively treat ventricular arrhythmias, making it an incorrect choice. Option D: Quinidine – Quinidine is a Class IA antiarrhythmic drug that blocks sodium and potassium channels. While it can be used for ventricular arrhythmias, it is associated with QT prolongation, torsades de pointes, and significant proarrhythmic effects, making amiodarone a safer and more effective choice for lidocaine-refractory ventricular arrhythmias.",
      "correct_choice_id": 294346,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48530411698479209/48530411698479209.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48530411698479209/48530411698479209.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60942,
      "choices": [
        {
          "id": 294349,
          "text": "0.5 to 2 ug/ m L"
        },
        {
          "id": 294350,
          "text": "0.25 to 0.5 ug/ mL"
        },
        {
          "id": 294351,
          "text": "to 0.20 ug/ mL"
        },
        {
          "id": 294352,
          "text": "to 4 ug/ Ml"
        }
      ],
      "text": "The proposed therapeutic plasma amiodarone concentration range is",
      "unique_key": "Q5331387",
      "question_audio": null,
      "question_video": null,
      "map_id": 34641334,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) 0.5 to 2 µg/mL. The therapeutic plasma concentration range of amiodarone is typically maintained between 0.5 to 2 µg/mL to ensure effective antiarrhythmic activity while minimizing toxicity. At this concentration, amiodarone effectively inhibits potassium channels (Class III action), along with sodium and calcium channels and beta-receptors, making it useful for treating both atrial and ventricular arrhythmias. Higher concentrations increase the risk of severe adverse effects, including pulmonary fibrosis, thyroid dysfunction, hepatotoxicity, and proarrhythmias. Explanation for incorrect options: Option B: 0.25 to 0.5 µg/mL – This concentration range is too low to achieve reliable antiarrhythmic efficacy. While some effects might be seen at the upper end of this range, it is generally below the therapeutic threshold for most patients. Option C: ? 0.20 µg/mL – This concentration is subtherapeutic and unlikely to provide any significant antiarrhythmic effects. At such low levels, amiodarone's efficacy in controlling arrhythmias is minimal, making this option incorrect. Option D: ? 4 µg/mL – This concentration is above the recommended therapeutic range and is associated with increased toxicity risk. Higher plasma levels of amiodarone can lead to pulmonary fibrosis, severe bradycardia, hypotension, thyroid dysfunction, and liver damage, making this an unsafe option.",
      "correct_choice_id": 294349,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60943,
      "choices": [
        {
          "id": 294353,
          "text": "Hepatitis"
        },
        {
          "id": 294354,
          "text": "Thrombocytopenia"
        },
        {
          "id": 294355,
          "text": "Bone marrow depression"
        },
        {
          "id": 294356,
          "text": "Diarrhea"
        }
      ],
      "text": "The most common adverse effect of Quinidine is",
      "unique_key": "Q7070894",
      "question_audio": null,
      "question_video": null,
      "map_id": 34542742,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Diarrhea. Diarrhea is the most common adverse effect of quinidine, occurring in up to 30% of patients. Quinidine, a Class IA antiarrhythmic, is known to cause gastrointestinal disturbances due to its anticholinergic properties and effects on smooth muscle motility. This can lead to nausea, vomiting, and diarrhea, which are dose-dependent and generally reversible upon dose adjustment or discontinuation of the drug. Explanation for incorrect options: Option A: Hepatitis – While quinidine can cause liver toxicity, hepatitis is a relatively rare side effect. Liver enzyme abnormalities are more common, but hepatitis is not the most frequent adverse effect seen with quinidine. Option B: Thrombocytopenia – Quinidine has been associated with thrombocytopenia in some cases, but it is not the most common adverse effect. Thrombocytopenia is a rare side effect, typically seen in immune-mediated reactions and occurs in a minority of patients. Option C: Bone marrow depression – Bone marrow depression is another rare side effect of quinidine. It can lead to leukopenia or agranulocytosis, but again, this is not the most common adverse effect. Bone marrow suppression is much less common compared to gastrointestinal side effects such as diarrhea.",
      "correct_choice_id": 294356,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62266191698479226/62266191698479226.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62266191698479226/62266191698479226.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60944,
      "choices": [
        {
          "id": 294357,
          "text": "The symptoms of procainamide-induced lupus resolve during treatment with N-acetyl Procainamide"
        },
        {
          "id": 294358,
          "text": "The lupus-like symptoms resolve on cessation of therapy"
        },
        {
          "id": 294359,
          "text": "Therapy should not be stopped because of the presence of antinuclear antibodies only without symptoms"
        },
        {
          "id": 294360,
          "text": "It is more common in rapid acetylators than slow acetylators"
        }
      ],
      "text": "Which of the following is incorrect regarding Procainamide induced lupus syndrome",
      "unique_key": "Q4512529",
      "question_audio": null,
      "question_video": null,
      "map_id": 34814083,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) It is more common in rapid acetylators than slow acetylators. Procainamide-induced lupus syndrome is actually more common in slow acetylators than in rapid acetylators. This is because procainamide is metabolized by the liver, and slow acetylators have a decreased ability to metabolize procainamide into its N-acetylated form, which accumulates in the body and is more likely to trigger autoimmune reactions, including lupus-like symptoms. Rapid acetylators clear the drug more quickly, which reduces the risk of developing lupus-like symptoms. Explanation for incorrect options: Option A: The symptoms of procainamide-induced lupus resolve during treatment with N-acetyl Procainamide – This statement is incorrect. The symptoms of lupus-like syndrome do not resolve with N-acetyl procainamide treatment. The treatment for procainamide-induced lupus generally involves discontinuation of the drug, and symptoms typically resolve within weeks to months after stopping the drug. N-acetyl procainamide does not reverse lupus-like symptoms. Option B: The lupus-like symptoms resolve on cessation of therapy – This statement is correct. The lupus-like symptoms caused by procainamide typically resolve after discontinuation of the drug, usually within several weeks. The symptoms are reversible once the drug is stopped. Option C: Therapy should not be stopped because of the presence of antinuclear antibodies only without symptoms – This statement is correct. The presence of antinuclear antibodies (ANA), which are commonly found in patients taking procainamide, does not necessitate discontinuing the drug unless symptoms of lupus (e.g., joint pain, rash, fever) appear. ANA positivity alone is not a reason to stop therapy if no clinical signs of lupus are present.",
      "correct_choice_id": 294360,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46302301698479239/46302301698479239.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46302301698479239/46302301698479239.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60945,
      "choices": [
        {
          "id": 294361,
          "text": "Lignocaine"
        },
        {
          "id": 294362,
          "text": "Esmolol"
        },
        {
          "id": 294363,
          "text": "Quinidine"
        },
        {
          "id": 294364,
          "text": "Flecainide"
        }
      ],
      "text": "Which of the following drugs can be cause QT prolongation",
      "unique_key": "Q3271449",
      "question_audio": null,
      "question_video": null,
      "map_id": 34297124,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Quinidine. Quinidine is a Class IA antiarrhythmic drug that prolongs the QT interval by inhibiting both sodium and potassium channels. Its potassium channel-blocking effect leads to prolonged repolarization, which can increase the risk of torsades de pointes and other ventricular arrhythmias. This makes quinidine a well-known drug that can cause QT interval prolongation in susceptible individuals. Explanation for incorrect options: Option A: Lignocaine (Lidocaine) – Lignocaine is a Class IB antiarrhythmic drug, and it is not known to cause QT prolongation. It works by blocking sodium channels, especially in depolarized tissues, but it has little to no effect on the repolarization phase of the action potential, so it does not significantly affect the QT interval. Option B: Esmolol – Esmolol is a Class II antiarrhythmic drug (beta-blocker), which primarily slows down the heart rate by blocking beta-adrenergic receptors. It does not typically cause QT prolongation, as its effect on the action potential duration is minimal. Its main effect is on heart rate and AV conduction, not repolarization. Option D: Flecainide – Flecainide is a Class IC antiarrhythmic drug that blocks sodium channels and is used to treat atrial and ventricular arrhythmias. While it can have proarrhythmic effects, it is not typically associated with QT prolongation. Instead, it can increase the risk of life-threatening arrhythmias in some cases, but QT prolongation is not a primary concern.",
      "correct_choice_id": 294363,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/16926521698479259/16926521698479259.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/16926521698479259/16926521698479259.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60946,
      "choices": [
        {
          "id": 294365,
          "text": "Propranolol"
        },
        {
          "id": 294366,
          "text": "Esmolol"
        },
        {
          "id": 294367,
          "text": "Sotalol"
        },
        {
          "id": 294368,
          "text": "Atenolol"
        }
      ],
      "text": "Which of the following Beta blocker is both class II and class III anti-arrhythmic drugs as per Vaughan-Williams classification",
      "unique_key": "Q2673661",
      "question_audio": null,
      "question_video": null,
      "map_id": 34774229,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Sotalol. Sotalol is a Class II and Class III antiarrhythmic drug as per the Vaughan-Williams classification. It acts as a beta-blocker (Class II), inhibiting beta-adrenergic receptors, and also as a potassium channel blocker (Class III), which prolongs repolarization and the action potential duration. This dual action makes sotalol effective in treating both atrial and ventricular arrhythmias. Its Class III properties give it the ability to prolong the QT interval, which is a key characteristic of this drug. Explanation for incorrect options: Option A: Propranolol – Propranolol is a Class II antiarrhythmic drug (beta-blocker) that works by blocking beta-adrenergic receptors and slowing the heart rate. However, it does not have any Class III (potassium channel-blocking) properties, so it is not classified as both Class II and Class III. Option B: Esmolol – Esmolol is a short-acting beta-blocker (Class II) used for rate control in supraventricular arrhythmias, but it does not have any Class III (potassium channel-blocking) properties. It is purely a Class II drug, without the dual Class II and III effects. Option D: Atenolol – Atenolol is another beta-blocker (Class II), similar to propranolol, and does not have Class III effects. It is used to treat hypertension and arrhythmias but lacks the potassium channel-blocking properties that define Class III drugs.",
      "correct_choice_id": 294367,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75829431698479280/75829431698479280.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75829431698479280/75829431698479280.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60947,
      "choices": [
        {
          "id": 294369,
          "text": "Lidocaine"
        },
        {
          "id": 294370,
          "text": "Procainamide"
        },
        {
          "id": 294371,
          "text": "Mexiletine"
        },
        {
          "id": 294372,
          "text": "Propafenone"
        }
      ],
      "text": "Which of the following is a class IC anti-arrhythmic drugs as per Vaughan-Williams classification",
      "unique_key": "Q5648332",
      "question_audio": null,
      "question_video": null,
      "map_id": 34955426,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Propafenone. Propafenone is classified as a Class IC antiarrhythmic drug according to the Vaughan-Williams classification. Class IC drugs are potent sodium channel blockers that significantly slow conduction velocity in cardiac tissues without affecting the action potential duration or repolarization. Propafenone, in addition to being a sodium channel blocker, also has mild beta-blocking properties, making it useful for ventricular and atrial arrhythmias, including atrial fibrillation. Explanation for incorrect options: Option A: Lidocaine – Lidocaine is a Class IB antiarrhythmic drug, not Class IC. It works by inhibiting sodium channels, but it is less potent than Class IC drugs and primarily affects depolarized tissues, such as those found in ventricular arrhythmias. Lidocaine has a short duration of action and does not significantly affect conduction velocity like Class IC drugs. Option B: Procainamide – Procainamide is classified as a Class IA antiarrhythmic drug. Class IA drugs, such as procainamide, block sodium channels and prolong the action potential duration by inhibiting potassium channels. Procainamide is used to treat both atrial and ventricular arrhythmias, but its effects are distinct from the pure sodium channel blockade seen in Class IC drugs like propafenone. Option C: Mexiletine – Mexiletine is a Class IB antiarrhythmic drug, similar to lidocaine, and works by blocking sodium channels but with less potency than Class IC drugs. It is primarily used to treat ventricular arrhythmias, particularly in patients with chronic arrhythmias. Mexiletine has no Class IC properties.",
      "correct_choice_id": 294372,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/67647631698479293/67647631698479293.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/67647631698479293/67647631698479293.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60948,
      "choices": [
        {
          "id": 294373,
          "text": "Recombinant BNP"
        },
        {
          "id": 294374,
          "text": "Recombinant ANP"
        },
        {
          "id": 294375,
          "text": "Synthetic form of urodilatin"
        },
        {
          "id": 294376,
          "text": "Synthetic calcitonin"
        }
      ],
      "text": "Carperitide is a",
      "unique_key": "Q7878596",
      "question_audio": null,
      "question_video": null,
      "map_id": 34319503,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Recombinant ANP. Carperitide is a recombinant form of atrial natriuretic peptide (ANP), which is a peptide hormone naturally produced in the atria of the heart. ANP plays a key role in regulating blood pressure and fluid balance by promoting vasodilation and natriuresis (excretion of sodium in urine), and diuresis (increased urine production). Carperitide mimics these effects and is used in the management of acute heart failure to improve symptoms by reducing preload and afterload, thus easing the heart's workload. Explanation for incorrect options: Option A: Recombinant BNP – B-type natriuretic peptide (BNP) is another peptide hormone involved in the regulation of blood pressure and fluid balance, particularly in the ventricles of the heart. While BNP has similar effects to ANP, carperitide is specifically a recombinant form of ANP, not BNP, making this option incorrect. Option C: Synthetic form of urodilatin – Urodilatin is a renal natriuretic peptide that is structurally similar to ANP, and it is involved in regulating renal sodium and water excretion. While carperitide shares some similarities with urodilatin, it is not a synthetic form of urodilatin. Carperitide is derived from ANP, not urodilatin. Option D: Synthetic calcitonin – Calcitonin is a hormone involved in calcium and bone metabolism, and it has no direct relation to the effects of carperitide. Carperitide, being a recombinant form of ANP, is unrelated to calcitonin, making this option incorrect.",
      "correct_choice_id": 294374,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/78914801698479311/78914801698479311.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/78914801698479311/78914801698479311.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60949,
      "choices": [
        {
          "id": 294377,
          "text": "By decreasing cardiac contractility"
        },
        {
          "id": 294378,
          "text": "Na+ K+ ATPase inhibition"
        },
        {
          "id": 294379,
          "text": "By causing bradycardia"
        },
        {
          "id": 294380,
          "text": "Increase in Refractoriness of AV nodal tissue"
        }
      ],
      "text": "Mechanism of action of digitalis in atrial fibrillation is",
      "unique_key": "Q6363292",
      "question_audio": null,
      "question_video": null,
      "map_id": 34607723,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Increase in Refractoriness of AV nodal tissue. The primary mechanism by which digitalis (digoxin) works in atrial fibrillation (AF) is by increasing the refractoriness of the AV node. By inhibiting the Na+/K+ ATPase pump, digoxin leads to an increase in intracellular calcium, which in turn enhances the refractoriness of the AV node. This prevents the rapid atrial impulses from being transmitted to the ventricles, helping to slow down the ventricular response rate in atrial fibrillation. This effect is key in controlling the rate of the heart in AF. Explanation for incorrect options: Option A: By decreasing cardiac contractility – This is incorrect. While digitalis does have a positive inotropic effect (increasing cardiac contractility), this is not the primary mechanism by which it works in atrial fibrillation. The main effect in AF is related to rate control through the AV node, not the contractility of the heart. Option B: Na+ K+ ATPase inhibition – While it is true that digitalis works by inhibiting the Na+/K+ ATPase pump, this action primarily leads to increased intracellular calcium, which ultimately increases the force of contraction (positive inotropy) and modifies electrical activity. However, Na+/K+ ATPase inhibition is not the direct mechanism by which digitalis specifically controls the ventricular rate in atrial fibrillation. Option C: By causing bradycardia – While bradycardia (slowing of the heart rate) may result as a secondary effect of digitalis, it is not the direct mechanism by which it controls atrial fibrillation. The slowing of the ventricular response in AF is due to the increased refractoriness of the AV node, not simply bradycardia.",
      "correct_choice_id": 294380,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/8274911698479403/8274911698479403.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/8274911698479403/8274911698479403.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60950,
      "choices": [
        {
          "id": 294381,
          "text": "PDE 4"
        },
        {
          "id": 294382,
          "text": "PDE 5"
        },
        {
          "id": 294383,
          "text": "PDE 2"
        },
        {
          "id": 294384,
          "text": "PDE 3"
        }
      ],
      "text": "Amrinone inhibits",
      "unique_key": "Q9378909",
      "question_audio": null,
      "question_video": null,
      "map_id": 34390520,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) PDE 3. Amrinone is a phosphodiesterase type 3 (PDE3) inhibitor. By inhibiting PDE3, amrinone increases intracellular cAMP levels, which leads to enhanced calcium influx into the heart muscle and smooth muscle relaxation. This results in a positive inotropic effect (increased cardiac contractility) and vasodilation, which is useful in the treatment of heart failure. The action of amrinone on PDE3 helps improve both cardiac output and vascular tone. Explanation for incorrect options: Option A: PDE 4 – PDE 4 primarily acts on the breakdown of cAMP in inflammatory cells. Inhibition of PDE4 may be used for conditions like inflammatory diseases, but it is not the target of amrinone. Therefore, amrinone does not inhibit PDE4. Option B: PDE 5 – PDE 5 primarily degrades cGMP, and its inhibition is important in the treatment of erectile dysfunction (e.g., with drugs like sildenafil). However, amrinone specifically inhibits PDE 3, not PDE 5. Option C: PDE 2 – PDE 2 is another subtype involved in the degradation of cAMP, but it is not the target of amrinone. Amrinone's therapeutic action is based on PDE 3 inhibition, not PDE 2.",
      "correct_choice_id": 294384,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24219611698479427/24219611698479427.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24219611698479427/24219611698479427.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60951,
      "choices": [
        {
          "id": 294385,
          "text": "Warfarin"
        },
        {
          "id": 294386,
          "text": "Bretylium"
        },
        {
          "id": 294387,
          "text": "Lidocaine"
        },
        {
          "id": 294388,
          "text": "Adenosine"
        }
      ],
      "text": "Which of the following medications would be prescribed most frequently to patients suffering from chronic atrial fibrillation?",
      "unique_key": "Q6031130",
      "question_audio": null,
      "question_video": null,
      "map_id": 34244034,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Warfarin Explanation: Warfarin is the most frequently prescribed medication for patients with chronic atrial fibrillation (AF) because it is an oral anticoagulant that helps prevent thromboembolic complications, particularly stroke. Atrial fibrillation causes irregular atrial contractions, leading to blood stasis in the atria and an increased risk of thrombus formation, particularly in the left atrial appendage. These thrombi can embolize and cause ischemic stroke or systemic embolism. Warfarin works by inhibiting vitamin K-dependent clotting factors (II, VII, IX, X), reducing the risk of clot formation. Explanation for Incorrect Options: (B) Bretylium – Bretylium is an antiarrhythmic drug primarily used for ventricular arrhythmias, particularly in cases of ventricular fibrillation or ventricular tachycardia refractory to other treatments. It has no role in managing chronic atrial fibrillation. (C) Lidocaine – Lidocaine is a class IB antiarrhythmic, used mainly for ventricular arrhythmias (e.g., post-myocardial infarction). It has no significant effect on atrial fibrillation as it primarily affects ventricular conduction. (D) Adenosine – Adenosine is used for paroxysmal supraventricular tachycardia (PSVT) and works by blocking AV nodal conduction. However, it is not effective for chronic atrial fibrillation, as AF is not dependent on AV nodal reentry but originates from ectopic foci in the atria.",
      "correct_choice_id": 294385,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28470701698479802/28470701698479802.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28470701698479802/28470701698479802.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60952,
      "choices": [
        {
          "id": 294389,
          "text": "Decrease the beta-blocker dose."
        },
        {
          "id": 294390,
          "text": "Refer for coronary angiography."
        },
        {
          "id": 294391,
          "text": "Refer for permanent pacemaker implantation."
        },
        {
          "id": 294392,
          "text": "Insert a temporary trans venous pacemaker."
        }
      ],
      "text": "A 64-year-old male had an inferior STEMI and was treated with aspirin, beta-blockers, an angiotensin-converting enzyme inhibitor, and a statin. He was standing at the nurse's station when telemetry showed the following: Wenckebach. Which of the following should you do?",
      "unique_key": "Q5684034",
      "question_audio": null,
      "question_video": null,
      "map_id": 34684221,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Decrease the beta-blocker dose Explanation: Wenckebach (Mobitz Type I second-degree AV block) is a common transient rhythm disturbance in inferior STEMI, often due to increased vagal tone or ischemia affecting the AV node. Since the patient is asymptomatic and ambulatory, immediate intervention beyond reducing exacerbating factors is not required. Beta-blockers slow AV nodal conduction, potentially worsening Wenckebach block. Reducing the beta-blocker dose helps alleviate the AV nodal suppression, potentially resolving the conduction delay. Most cases of Wenckebach due to inferior STEMI are self-limiting and do not require a pacemaker unless they progress to symptomatic bradycardia or high-degree AV block. Explanation for Incorrect Options: (B) Refer for coronary angiography – Coronary angiography is typically indicated for persistent ischemia, recurrent angina, or hemodynamic instability post-STEMI. Since the patient is clinically stable with no ongoing ischemic symptoms, angiography is not immediately necessary for Wenckebach alone. (C) Refer for permanent pacemaker implantation – Wenckebach block is usually transient in inferior STEMI and resolves as the ischemia subsides. A permanent pacemaker is reserved for symptomatic bradycardia or high-degree AV block (Mobitz II or third-degree AV block). Given the patient’s stable condition, this is not warranted. (D) Insert a temporary transvenous pacemaker – This is indicated for symptomatic bradycardia or hemodynamically unstable high-degree AV block. Since the patient is ambulatory and asymptomatic, a temporary pacemaker is unnecessary.",
      "correct_choice_id": 294389,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/320831698479818/320831698479818.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/320831698479818/320831698479818.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60953,
      "choices": [
        {
          "id": 294393,
          "text": "Hypocalcemia"
        },
        {
          "id": 294394,
          "text": "Hypernatremia"
        },
        {
          "id": 294395,
          "text": "Hyperkalemia"
        },
        {
          "id": 294396,
          "text": "Hypomagnesemia"
        }
      ],
      "text": "An ECG for a 43-year-old female demonstrates the following rhythm: Torsades. Which of the following electrolyte abnormalities is most likely to cause this rhythm?",
      "unique_key": "Q6540977",
      "question_audio": null,
      "question_video": null,
      "map_id": 34105621,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Hypomagnesemia Explanation: Torsades de Pointes (TdP) is a specific type of polymorphic ventricular tachycardia that is associated with prolonged QT intervals. Hypomagnesemia is one of the most common causes of Torsades. Magnesium plays a crucial role in stabilizing cell membranes and in the regulation of potassium and calcium channels, which are essential for proper cardiac conduction. Low magnesium levels can lead to QT prolongation, increased early afterdepolarizations, and triggered activity, which can result in Torsades. Therefore, hypomagnesemia is most likely to be responsible for causing this arrhythmia. Explanation for Incorrect Options: (A) Hypocalcemia: While hypocalcemia can lead to prolonged QT intervals and predispose to arrhythmias, it is not typically associated with Torsades de Pointes in the same way as hypomagnesemia. Hypocalcemia can affect the duration of the QT interval, but it is less likely to directly cause Torsades compared to magnesium deficiency. The relationship between calcium levels and Torsades is not as strong as that with magnesium. (B) Hypernatremia: Hypernatremia, or high levels of sodium, is usually associated with cellular dehydration and may cause neurological symptoms or altered mental status, but it is not typically linked to Torsades de Pointes. Sodium plays a crucial role in action potential generation, but hypernatremia does not directly lead to the development of prolonged QT intervals or early afterdepolarizations, which are central to Torsades. (C) Hyperkalemia: Hyperkalemia (high potassium levels) can cause various arrhythmias, such as bradycardia, ventricular arrhythmias, and heart block. It does not typically lead to Torsades de Pointes, which is more specifically associated with abnormalities in the QT interval and triggered activity. Hyperkalemia generally results in decreased myocardial excitability rather than the early afterdepolarizations seen in Torsades.",
      "correct_choice_id": 294396,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/76925161698479882/76925161698479882.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/76925161698479882/76925161698479882.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60954,
      "choices": [
        {
          "id": 294397,
          "text": "Tocainide"
        },
        {
          "id": 294398,
          "text": "Verapamil"
        },
        {
          "id": 294399,
          "text": "Procainamide"
        },
        {
          "id": 294400,
          "text": "Flecainide"
        }
      ],
      "text": "A 26 year old male presented to you with irregular pulse rate, diziness, history of syncope in recent past. On proper diagnosis he is found to be suffering from atrial flutter and immediately started with antiarrythmic treatment. After few weeks of therapy patient again comes to emergency department in unconsious state with BP 90/60. Resident doctor has taken ECG and found changes given below Which drug is responsible for above changes?<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/1(188).jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6652505",
      "question_audio": null,
      "question_video": null,
      "map_id": 34514706,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Procainamide. Procainamide is a Class 1A antiarrhythmic that is commonly used to treat arrhythmias like atrial flutter. It works by blocking sodium channels and prolonging the action potential, which can be beneficial in stabilizing the heart rhythm in conditions like atrial flutter. However, one of the notable adverse effects of procainamide is that it can cause hypotension, especially in situations where the drug is administered intravenously or when the patient has underlying cardiac or renal issues. This can lead to a drop in blood pressure, as described in the clinical scenario (BP 90/60). Furthermore, procainamide can cause prolonged QT interval and Torsades de Pointes (a form of polymorphic ventricular tachycardia), which could explain the changes seen on the ECG. Explanation of Incorrect Options: (A) Tocainide – Incorrect. Tocainide is also a Class 1B antiarrhythmic but is less commonly used compared to procainamide. It has a shorter duration of action and does not typically cause the same significant hypotension or QT interval prolongation associated with procainamide. Therefore, it is unlikely to be responsible for the changes in this scenario. (B) Verapamil – Incorrect. Verapamil is a calcium channel blocker that is used to treat arrhythmias like atrial fibrillation and atrial flutter. While it can cause bradycardia and hypotension, especially when given with other medications like beta-blockers, it is less likely to cause the severe hypotension or prolonged QT interval seen in this case. The ECG changes described are more consistent with a Class 1A drug like procainamide. (D) Flecainide – Incorrect. Flecainide is a Class 1C antiarrhythmic that is used to treat supraventricular arrhythmias, including atrial flutter. It can cause bradycardia, heart block, and proarrhythmic effects, but it does not typically lead to the hypotension or ECG changes (such as prolonged QT) seen with procainamide. Therefore, flecainide is less likely to be the cause of the patient's symptoms and ECG changes.",
      "correct_choice_id": 294399,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34685081700304792/34685081700304792.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34685081700304792/34685081700304792.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60955,
      "choices": [
        {
          "id": 294401,
          "text": "Digoxin"
        },
        {
          "id": 294402,
          "text": "Amiodarone"
        },
        {
          "id": 294403,
          "text": "Warfarin"
        },
        {
          "id": 294404,
          "text": "Tocainide"
        }
      ],
      "text": "A patient, who was suffering from WPW syndrome, started taking a drug and now come to you with hyper pigmentation of skin and slit lamp examination finding in eyes is given below . Which of the following drug is responsible for these changes ?<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/5(115).jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6024221",
      "question_audio": null,
      "question_video": null,
      "map_id": 34027898,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Amiodarone. Amiodarone is an antiarrhythmic medication commonly used in the treatment of arrhythmias such as WPW syndrome (Wolff-Parkinson-White syndrome). It is known for its potential side effects, including skin hyperpigmentation and corneal microdeposits visible on slit-lamp examination. These changes are due to the iodine content in amiodarone, which leads to the accumulation of the drug in various tissues, including the skin and eyes. The hyperpigmentation typically appears as a bluish-gray discoloration of the skin, especially in areas exposed to the sun. Corneal microdeposits can cause visual disturbances, though they are usually asymptomatic. Explanation of Incorrect Options: (A) Digoxin – Incorrect. Digoxin is a cardiac glycoside used for the treatment of heart failure and atrial arrhythmias. While it can cause visual disturbances like yellow-green halos around objects (a sign of digoxin toxicity), it does not cause skin hyperpigmentation or corneal microdeposits. Therefore, digoxin is not responsible for the described findings. (C) Warfarin – Incorrect. Warfarin is an anticoagulant used to prevent thromboembolic events. It can cause skin necrosis or purple toes syndrome, but it does not cause skin hyperpigmentation or corneal microdeposits. These findings are not associated with warfarin therapy. (D) Tocainide – Incorrect. Tocainide is an antiarrhythmic medication used to treat ventricular arrhythmias. Although it has a similar mechanism to lidocaine, it does not typically cause skin hyperpigmentation or corneal microdeposits. These side effects are more characteristic of amiodarone rather than tocainide.",
      "correct_choice_id": 294402,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/25441411700304958/25441411700304958.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/25441411700304958/25441411700304958.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60956,
      "choices": [
        {
          "id": 294405,
          "text": "Amiodarone"
        },
        {
          "id": 294406,
          "text": "Digoxin"
        },
        {
          "id": 294407,
          "text": "Lidocaine"
        },
        {
          "id": 294408,
          "text": "Procainamide"
        }
      ],
      "text": "A 68-year-old man is brought to the emergency department complaining of crushing chest pain radiating to his left arm. He is admitted, stabilized, and treated for an acute myocardial infarction. Later, he developed ventricular tachycardia and is treated with an antiarrhythmic. After a week of antiarrhythmic treatment, he began having difficulty breathing. A chest X-ray reveals pulmonary fibrosis. Which antiarrhythmic was he taking?",
      "unique_key": "Q7808389",
      "question_audio": null,
      "question_video": null,
      "map_id": 34239424,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Amiodarone. Amiodarone is a Class III antiarrhythmic drug commonly used to treat ventricular tachycardia and atrial fibrillation. It works by blocking potassium channels, prolonging the action potential and refractory period, which helps in stabilizing cardiac rhythm. However, amiodarone is highly lipophilic and accumulates in multiple organs, leading to serious long-term side effects. Pulmonary fibrosis is one of its most severe complications, often presenting as progressive dyspnea, cough, and interstitial lung disease, as seen in this patient. This occurs due to direct toxicity and an immune-mediated reaction. A chest X-ray or high-resolution CT scan typically reveals interstitial lung disease or pulmonary fibrosis. Discontinuation of amiodarone is crucial once pulmonary toxicity is suspected. Explanation of Incorrect Options: (B) Digoxin: Digoxin is a cardiac glycoside used to treat heart failure and atrial fibrillation by inhibiting Na+/K+ ATPase, leading to increased intracellular calcium and stronger myocardial contractions. While digoxin toxicity can cause nausea, vomiting, blurred vision (yellow halos), and life-threatening arrhythmias, it does not cause pulmonary fibrosis. (C) Lidocaine: Lidocaine is a Class IB antiarrhythmic used primarily for acute ventricular arrhythmias, especially in the setting of myocardial infarction. It works by blocking sodium channels, decreasing the action potential duration in ischemic cardiac tissue. Although it has potential side effects like CNS toxicity (confusion, seizures, tremors) and cardiovascular depression, it does not cause pulmonary fibrosis. (D) Procainamide: Procainamide is a Class IA antiarrhythmic that blocks sodium channels, slowing conduction velocity and prolonging the action potential. It is associated with drug-induced lupus erythematosus (DILE), which can present with fever, joint pain, and a positive anti-histone antibody test, but not pulmonary fibrosis.",
      "correct_choice_id": 294405,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/21897331700305441/21897331700305441.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/21897331700305441/21897331700305441.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60957,
      "choices": [
        {
          "id": 294409,
          "text": "Class Ia"
        },
        {
          "id": 294410,
          "text": "Class Ib"
        },
        {
          "id": 294411,
          "text": "Class Ic"
        },
        {
          "id": 294412,
          "text": "Class II"
        }
      ],
      "text": "A 60-year-old man undergoes open-heart surgery for a triple coronary artery bypass graft. His surgery goes smoothly, but the next day he develops chest palpitations. Metoprolol is started to keep his supraventricular tachycardia from interfering with ventricular rhythm. Under which Singh–Vaughan Williams class of antiarrhythmics does metoprolol fall?",
      "unique_key": "Q9981433",
      "question_audio": null,
      "question_video": null,
      "map_id": 34541748,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Class II. Metoprolol is a beta-blocker that falls under Class II of the Singh–Vaughan Williams classification of antiarrhythmic drugs. Class II antiarrhythmics work by blocking beta-adrenergic receptors, leading to a decrease in sympathetic stimulation of the heart. This results in: Decreased SA node automaticity Slowed AV node conduction, prolonging the PR interval Reduced myocardial contractility These effects make beta-blockers particularly useful in treating supraventricular tachycardias (SVTs), atrial fibrillation, and atrial flutter, as seen in this patient after open-heart surgery. Postoperative arrhythmias, especially atrial fibrillation or SVTs, are common after cardiac surgery due to inflammation and autonomic changes. Metoprolol helps control the heart rate by slowing AV nodal conduction and is often the first-line treatment in such cases. Explanation of Incorrect Options: (A) Class Ia: Class Ia antiarrhythmics (e.g., quinidine, procainamide, disopyramide) block sodium channels, slowing depolarization, and also block potassium channels, prolonging the action potential. These drugs are used for atrial and ventricular arrhythmias, but they are not beta-blockers and do not act through sympathetic inhibition like metoprolol. (B) Class Ib: Class Ib antiarrhythmics (e.g., lidocaine, mexiletine) selectively block sodium channels in ischemic or depolarized ventricular cells. They are primarily used for ventricular arrhythmias (especially post-myocardial infarction). They do not significantly affect the AV node, making them ineffective for supraventricular tachycardias. (C) Class Ic: Class Ic antiarrhythmics (e.g., flecainide, propafenone) strongly block sodium channels, significantly slowing conduction velocity without affecting repolarization. They are used for supraventricular and ventricular arrhythmias, but they are not beta-blockers and do not have the same autonomic effects as metoprolol. Additionally, Class Ic drugs are contraindicated in patients with structural heart disease, like those post-bypass surgery, due to the risk of proarrhythmic effects.",
      "correct_choice_id": 294412,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40404831700305455/40404831700305455.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40404831700305455/40404831700305455.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60958,
      "choices": [
        {
          "id": 294413,
          "text": "Hepatitis"
        },
        {
          "id": 294414,
          "text": "Hypertrophic cardiomyopathy"
        },
        {
          "id": 294415,
          "text": "Iatrogenic hyperthyroidism"
        },
        {
          "id": 294416,
          "text": "Iodine accumulation"
        }
      ],
      "text": "A 67-year-old woman with a history of cardiac arrhythmias presents to her primary care physician for follow-up. Her current medications include amiodarone. She complains of a 4-week history of diarrhea, sweats, and muscle weakness. Her skin is normal. Which of the following is the most likely explanation for these findings?",
      "unique_key": "Q5353119",
      "question_audio": null,
      "question_video": null,
      "map_id": 34878931,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Iatrogenic hyperthyroidism. Amiodarone, a class III antiarrhythmic drug, contains a high iodine content and can cause thyroid dysfunction, leading to either hyperthyroidism or hypothyroidism. Amiodarone-induced hyperthyroidism (AIH) occurs due to: Excess iodine (Jod-Basedow phenomenon) stimulating thyroid hormone synthesis in patients with pre-existing thyroid disease. Destructive thyroiditis causing leakage of preformed thyroid hormones. Symptoms of hyperthyroidism (seen in this patient) include: Diarrhea (due to increased gut motility). Sweating and heat intolerance (due to increased metabolism). Muscle weakness (thyrotoxic myopathy). Amiodarone-induced thyroid dysfunction is common, and patients on long-term therapy should be monitored for thyroid function abnormalities. Explanation of Incorrect Options: (A) Hepatitis: Amiodarone can cause hepatotoxicity, but it typically presents with elevated liver enzymes and jaundice, not with diarrhea, sweating, or muscle weakness. This patient has thyrotoxic symptoms, which are not explained by liver dysfunction. (B) Hypertrophic cardiomyopathy (HCM): HCM is a genetic condition causing left ventricular hypertrophy and diastolic dysfunction. Symptoms include exertional dyspnea, chest pain, and syncope, but not diarrhea or sweating. Amiodarone is used for arrhythmias but does not cause HCM. (D) Iodine accumulation: Amiodarone contains iodine, but iodine accumulation itself does not cause symptoms. The symptoms result from thyroid dysfunction (either hyperthyroidism or hypothyroidism) rather than iodine buildup alone.",
      "correct_choice_id": 294415,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/27498651700305498/27498651700305498.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/27498651700305498/27498651700305498.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60959,
      "choices": [
        {
          "id": 294417,
          "text": "Adenosine"
        },
        {
          "id": 294418,
          "text": "Flecainide"
        },
        {
          "id": 294419,
          "text": "Lidocaine"
        },
        {
          "id": 294420,
          "text": "Phenytoin"
        }
      ],
      "text": "A 68 -year-old man is brought to the emergency department after he passed out at home. Electrocardiography reveals an AV nodal–based arrhythmia. What drug would be most effective at interrupting the AV transmission and breaking the arrhythmic cycle at the AV node?",
      "unique_key": "Q9554374",
      "question_audio": null,
      "question_video": null,
      "map_id": 34189602,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Adenosine. Adenosine is the drug of choice for treating AV nodal-based arrhythmias, such as paroxysmal supraventricular tachycardia (PSVT). Mechanism of Action: Adenosine binds to A1 receptors in the AV node, causing inhibition of adenylate cyclase. This leads to increased outward potassium current, which hyperpolarizes the AV node and temporarily blocks AV conduction. The result is interruption of the reentrant circuit, restoring normal sinus rhythm. Clinical Use: Rapid IV bolus (short half-life ~10 seconds). Used to acutely terminate AV node–dependent arrhythmias (e.g., PSVT, AVNRT). Side effects: Flushing, hypotension, chest pain, sense of impending doom, and transient asystole (brief heart stoppage). Explanation of Incorrect Options: (B) Flecainide: Class IC antiarrhythmic that blocks fast sodium channels, slowing conduction in the His-Purkinje system and ventricular myocardium. Used for atrial fibrillation and ventricular tachycardia, but not effective in terminating AV nodal reentrant tachycardias. Proarrhythmic effects, especially in patients with structural heart disease. (C) Lidocaine: Class IB antiarrhythmic, blocks sodium channels in ischemic ventricular myocardium. Used for ventricular arrhythmias (especially post-myocardial infarction). Not effective for AV node–dependent arrhythmias. (D) Phenytoin: Primarily an anticonvulsant but can act as a Class IB antiarrhythmic. Used off-label for digitalis-induced ventricular arrhythmias, not for AV nodal arrhythmias.",
      "correct_choice_id": 294417,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/17682051700305519/17682051700305519.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/17682051700305519/17682051700305519.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60960,
      "choices": [
        {
          "id": 294421,
          "text": "Acetazolamide"
        },
        {
          "id": 294422,
          "text": "Chlorthalidone"
        },
        {
          "id": 294423,
          "text": "Furosemide"
        },
        {
          "id": 294424,
          "text": "Hydrochlorothiazide"
        }
      ],
      "text": "A 78-year-old man with dyspnea is brought to the emergency department for evaluation. Physical examination reveals jugular venous distension and bilateral rales in both lung fields. Chest X-ray reveals pulmonary congestion consistent with fluid overload. What is the best treatment for this patient?",
      "unique_key": "Q2153538",
      "question_audio": null,
      "question_video": null,
      "map_id": 34340406,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Furosemide. This patient presents with dyspnea, jugular venous distension (JVD), pulmonary congestion, and fluid overload, which are classic signs of acute decompensated heart failure (ADHF). The best treatment is furosemide, a loop diuretic that rapidly reduces pulmonary and systemic congestion by promoting diuresis (fluid removal). Mechanism of Action of Furosemide: Inhibits the Na+/K+/2Cl- cotransporter in the thick ascending limb of the loop of Henle. Increases sodium, chloride, and water excretion, leading to rapid diuresis. Reduces preload and afterload, thereby decreasing pulmonary congestion and improving dyspnea. Clinical Use: First-line treatment for acute heart failure with fluid overload. Used in pulmonary edema, hypertension, and other edematous states (e.g., cirrhosis, nephrotic syndrome). Explanation of Incorrect Options: (A) Acetazolamide: Carbonic anhydrase inhibitor, works in the proximal tubule to promote bicarbonate diuresis. Used for glaucoma, metabolic alkalosis, and altitude sickness, but not effective in managing acute pulmonary congestion. (B) Chlorthalidone: Thiazide diuretic that inhibits the Na+/Cl+ transporter in the distal convoluted tubule. Mild diuretic effect, used for hypertension and long-term management of mild fluid retention, but not potent enough for acute pulmonary congestion. (D) Hydrochlorothiazide: Another thiazide diuretic, similar to chlorthalidone. Primarily used for hypertension and mild peripheral edema, but ineffective for acute pulmonary edema because it does not cause rapid fluid removal.",
      "correct_choice_id": 294423,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/8123991700305541/8123991700305541.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/8123991700305541/8123991700305541.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60961,
      "choices": [
        {
          "id": 294425,
          "text": "Diltiazem"
        },
        {
          "id": 294426,
          "text": "Nitroprusside"
        },
        {
          "id": 294427,
          "text": "Hydralazine"
        },
        {
          "id": 294428,
          "text": "Enalapril"
        }
      ],
      "text": "Which of the following drugs can cause reflex tachycardia as a side effect due to its action on blood vessels?",
      "unique_key": "Q6578052",
      "question_audio": null,
      "question_video": null,
      "map_id": 34985993,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Hydralazine. Hydralazine is a direct arterial vasodilator that primarily reduces afterload by relaxing vascular smooth muscle. This vasodilation leads to a decrease in blood pressure, which triggers a baroreceptor-mediated reflex tachycardia as the body attempts to compensate for the sudden drop in vascular resistance. Reflex tachycardia is a well-known side effect of hydralazine, making it less suitable for patients with ischemic heart disease since an increased heart rate can worsen myocardial oxygen demand and potentially lead to angina. Due to its strong vasodilatory effect, hydralazine is often used in combination with a beta-blocker to counteract this reflex tachycardia. Explanation of Incorrect Options: (A) Diltiazem – Incorrect. Diltiazem is a calcium channel blocker (CCB) of the nondihydropyridine class, which exerts both vasodilatory and negative chronotropic (heart rate-lowering) effects. Unlike dihydropyridine CCBs (e.g., nifedipine), diltiazem does not cause significant reflex tachycardia because it directly suppresses sinoatrial (SA) node activity, leading to a reduced heart rate. Instead, it is often used to control tachyarrhythmias like atrial fibrillation. (B) Nitroprusside – Incorrect. Nitroprusside is a potent vasodilator that affects both arteries and veins, leading to a reduction in both afterload and preload. While hypotension due to nitroprusside can trigger reflex tachycardia, this effect is usually less pronounced compared to selective arterial vasodilators like hydralazine. Moreover, nitroprusside has a rapid onset and short duration, making reflex responses less sustained. (D) Enalapril – Incorrect. Enalapril is an angiotensin-converting enzyme (ACE) inhibitor that lowers blood pressure by blocking the conversion of angiotensin I to angiotensin II, leading to vasodilation and decreased aldosterone secretion. Unlike direct vasodilators, ACE inhibitors typically do not cause reflex tachycardia because they reduce sympathetic activation and improve baroreceptor sensitivity. Instead, enalapril is known for side effects like dry cough, hyperkalemia, and angioedema rather than reflex tachycardia.",
      "correct_choice_id": 294427,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/37204681727532746/37204681727532746.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/37204681727532746/37204681727532746.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60962,
      "choices": [
        {
          "id": 294429,
          "text": "Administer oral vitamin K"
        },
        {
          "id": 294430,
          "text": "Administer intravenous vitamin K and prothrombin complex concentrate"
        },
        {
          "id": 294431,
          "text": "Discontinue warfarin and start heparin"
        },
        {
          "id": 294432,
          "text": "Administer a platelet transfusion"
        }
      ],
      "text": "A 72-year-old woman with a history of atrial fibrillation and chronic kidney disease is currently on warfarin. She develops severe bleeding complications, and the INR is significantly elevated. Which of the following is the most appropriate immediate treatment for her bleeding?",
      "unique_key": "Q7722417",
      "question_audio": null,
      "question_video": null,
      "map_id": 34060099,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Administer intravenous vitamin K and prothrombin complex concentrate. In a patient with severe bleeding and an elevated INR due to warfarin use, the most appropriate treatment is to reverse the anticoagulant effect quickly. Intravenous vitamin K (often phytonadione) is used to restore the synthesis of vitamin K-dependent clotting factors (II, VII, IX, and X). However, since the bleeding is severe and the INR is significantly elevated, prothrombin complex concentrate (PCC) or fresh frozen plasma (FFP) should be administered in conjunction with vitamin K to provide immediate clotting factor replacement. PCC is preferred over FFP because it contains a more concentrated dose of clotting factors and has a faster onset of action, providing more rapid hemostasis in urgent situations. This combination is the most effective and widely recommended approach for acute warfarin reversal in bleeding patients. Explanation of Incorrect Options: (A) Administer oral vitamin K – Incorrect. Oral vitamin K can be used to reverse warfarin's effects in non-urgent settings, especially for mild elevations in INR or when bleeding is not severe. However, in this case, the patient has severe bleeding, and oral vitamin K would take too long (typically 24–48 hours) to restore normal clotting function. Intravenous vitamin K is much faster-acting and should be used in cases of severe bleeding. (C) Discontinue warfarin and start heparin – Incorrect. Discontinuing warfarin is important to stop the anticoagulant effect, but this is not enough for immediate hemostasis in the setting of severe bleeding. Heparin is an anticoagulant, and its use would only further increase the risk of bleeding. The immediate goal is to reverse the effects of warfarin, and heparin would be counterproductive. Starting heparin could also complicate management, as the patient is already at risk of bleeding. (D) Administer a platelet transfusion – Incorrect. Platelet transfusions are indicated for bleeding due to thrombocytopenia (low platelet count), but not for warfarin-related bleeding. Warfarin causes bleeding by altering clotting factor function, not by a defect in platelet function. Therefore, platelet transfusion is not effective for reversing the effects of warfarin or controlling warfarin-induced bleeding. The primary treatment here is clotting factor replacement, such as with PCC or FFP.",
      "correct_choice_id": 294430,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/72672971727681088/72672971727681088.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/72672971727681088/72672971727681088.m3u8",
      "question_images": [],
      "explanation_images": []
    }
  ]
}